首页> 外文期刊>Food Additives & Contaminants >Ochratoxin A: Comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans)
【24h】

Ochratoxin A: Comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans)

机译:ch曲毒素A:比较药代动力学和毒理学影响(实验和家养动物和人类)

获取原文
获取原文并翻译 | 示例
           

摘要

The causal factors for the species- and sex-differences associated with ochratoxin-mediated toxicity remain unclear. Variations in kinetic parameters may play a major role in explaining these differences, however, discrepancies and inaccuracies in the toxicokinetics reported in the literature for various species, make comparison and hence the extrapolation to the human situation impossible. The one- and two-compartment open models currently proposed may be insufficient to enable an accurate representation of the actual situation in vivo. It is likely that at least three if not four compartments must be assumed to account for the reported effects. The application of such models to existing raw data would most likely provide for a more accurate base set of toxicokinetic data and contribute to a more accurate human risk assessment. Possible explanations for the reported inconsistencies and their impact on the proposed mechanism(s) of action of OTA and risk assessment are discussed.
机译:与曲毒素介导的毒性相关的物种和性别差异的成因仍不清楚。动力学参数的变化可能在解释这些差异中起主要作用,但是,文献中针对各种物种报道的毒物动力学的差异和不准确性使得进行比较,因此无法推断出人类的情况。当前提出的一室和两室开放模型可能不足以准确地表示体内的实际情况。可能必须假定至少三个(如果不是四个)隔室来说明所报告的影响。将此类模型应用于现有原始数据很可能会提供更准确的毒物动力学数据基础集,并有助于更准确的人类风险评估。讨论了对所报告的不一致之处及其可能对OTA和风险评估的拟议行动机制产生影响的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号